Jean Rommelaere

USPTO Granted Patents = 33 (Patent Applications = 11)

CIPO Patents = 25 (Patent Applications = 3)

EPO Patents = 32 (Patent Applications = 48)

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 44(Granted Patents)

Company Filing History:

23 out of 155

Deutsches Krebsforschungszentrum

patents

8 out of 23

Ruprecht-Karls-Universitaet Heidelberg

patents

7 out of 160

Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts

patents

4. 7 out of 63

Ruprecht-Karls-Universitat Heidelberg

patents

5. 3 out of 20

Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts

Ruprecht-Karis-Universität Heidelberg

patents

8. 1 out of 4

Universitaetsklinikum Heidelberg

patents

where one patent can have more than one assignee

Years Active: 2005-2025

Loading Chart...

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12404498 - Optimized parvovirus H-1 production (2025-09-02),

2. 11964015 - Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor (2024-04-23),

3. 11324788 - Parvovirus formulation for treating tumors (2022-05-10),

4. 11193112 - Scalable process for oncolytic rat parvovirus H-1 production and purification based on isoelectric point-based elimination of empty particles (2021-12-07),

5. 11027013 - Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor (2021-06-08),

6. 10813959 - Cancer therapy with a parvovirus combined with bevacizumab (2020-10-27),

7. 10624935 - Parvovirus formulation for treating tumors (2020-04-21),

8. 10525091 - Use of parvovirus for eliminating cancer stem cells (CSCs) (2020-01-07),

9. 10406185 - Cancer therapy with a parvovirus combined with a BCL-2 inhibitor (2019-09-10),

10. 10266810 - Method for large scale production and purification of parvovirus (2019-04-23),

11. 10227609 - Modified parvovirus useful for gene silencing (2019-03-12),

12. 10098917 - Parovirus having a CpG-enriched genome useful for cancer therapy (2018-10-16),

13. 10058591 - Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer (2018-08-28),

14. 9889169 - Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor (2018-02-13),

15. 9861669 - Oncolytic virotherapy for prevention of tumor recurrence (2018-01-09),

Title: Jean Rommelaere: Pioneering Inventor from Heidelberg

Introduction: Jean Rommelaere is a distinguished inventor hailing from Heidelberg, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Jean Rommelaere holds several patents in the areas of renewable energy, artificial intelligence, and sustainable transportation, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With over two decades of experience in the tech industry, Jean Rommelaere has worked with leading research institutions and multinational companies to develop cutting-edge solutions that have revolutionized various sectors.

Collaborations: Throughout his career, Jean Rommelaere has collaborated with top engineers, scientists, and designers to bring his innovative ideas to life, resulting in successful products and technologies that have had a significant impact on society.

Conclusion: Jean Rommelaere's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, inspiring the next generation of innovators to push the boundaries of what is possible in the world of technology.

This text is generated by artificial intelligence and may not be accurate.